PHASE I, OPEN-LABEL, RANDOMIZED, SINGLE-DOSE STUDY TO ASSESS SAFETY AND PHARMACOKINETICS OF SUBCUTANEOUS ROZIBAFUSP ALFA IN HEALTHY JAPANESE SUBJECTS.

被引：0
|
作者：
Abuqayyas, L. [1 ]
Cheng, L. [2 ]
Simiens, M. [3 ]
Dutta, S. [3 ]
Houk, B. [3 ]
机构：
[1] Amgen Inc, Cambridge, MA USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Amgen Inc, Thousand Oaks, CA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2021年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-029
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [1] A Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese Subjects
    Trivedi, Ashit
    Mather, Omar
    Vega, Silvia
    Hutton, Shauna
    Hellawell, Jennifer
    Lee, Edward
    [J]. DRUGS IN R&D, 2022, 22 (02) : 141 - 146
  • [2] A Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese Subjects
    Ashit Trivedi
    Omar Mather
    Silvia Vega
    Shauna Hutton
    Jennifer Hellawell
    Edward Lee
    [J]. Drugs in R&D, 2022, 22 : 141 - 146
  • [3] A PHASE I, SINGLE-DOSE, RANDOMIZED, OPEN-LABEL, CROSSOVER, RELATIVE BIOAVAILABILITY, AND FOOD EFFECT STUDY OF BELVARAFENIB IN HEALTHY SUBJECTS.
    Malhi, V.
    Monemi, S.
    Dolton, M.
    Kapp, A.
    Angelaud, R.
    Zhang, W.
    Eng-Wong, J.
    Sullivan, C.
    Mueller, L.
    Musib, L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S43 - S43
  • [4] Pharmacokinetics, safety, and tolerability of sulcardine sulfate: an open-label, single-dose, randomized study in healthy Chinese subjects
    Chen, Qian
    Qian, Hong-jie
    Wang, Wei
    Zhang, Meng-qi
    Lu, Dong-ying
    Lu, Chuan
    Jin, Jie-mei
    Hu, Chao-ying
    Liu, Gang-yi
    Jia, Jing-ying
    Zheng, Hong-chao
    Li, Xue-ning
    Yu, Chen
    Wang, Yi-ping
    Liu, Yun
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 (01) : 120 - 125
  • [5] Pharmacokinetics and tolerability of sublingual fentanyl in healthy Japanese and Caucasian volunteers: Phase I, open-label single-dose study
    Lorch, U.
    Farrell, F.
    Kilborn, J.
    Tarnaoka, M.
    Derrick, R.
    Howell, J.
    [J]. PROCEEDINGS OF THE 13TH INTERNATIONAL PAIN CLINIC CONGRESS: WORLD SOCIETY OF PAIN CLINICIANS, 2008, : 131 - +
  • [6] AN OPEN-LABEL STUDY TO ASSESS THE EFFECT OF FOOD ON THE PHARMACOKINETICS OF SOTORASIB IN HEALTHY SUBJECTS.
    Cardona, P.
    Hutton, S.
    Purkis, J.
    Mather, O.
    Dutta, S.
    Houk, B.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S12 - S12
  • [7] Pharmacokinetics and Safety of Intravenous and Subcutaneous Auto-injector Single-dose Belimumab in Healthy Chinese Volunteers: A phase 1, Randomized, Open-label Study
    Meng, Xianmin
    Wang, Qianqian
    Wu, Shunquan
    Pu, Di
    Zhang, Amber
    Fang, Sun
    Zhou, Xuan
    Lu, Hongzhou
    [J]. RHEUMATOLOGY AND THERAPY, 2021, 8 (04) : 1711 - 1724
  • [8] Pharmacokinetics and Safety of Intravenous and Subcutaneous Auto-injector Single-dose Belimumab in Healthy Chinese Volunteers: A phase 1, Randomized, Open-label Study
    Xianmin Meng
    Qianqian Wang
    Shunquan Wu
    Di Pu
    Amber Zhang
    Sun Fang
    Xuan Zhou
    Hongzhou Lu
    [J]. Rheumatology and Therapy, 2021, 8 : 1711 - 1724
  • [9] Pharmacokinetics and Safety of Ezetimibe/Simvastatin Combination Tablet An Open-Label, Single-Dose Study in Healthy Chinese Subjects
    Chu, Nan-Nan
    Chen, Wei-Li
    Xu, Hong-Rong
    Li, Xue-Ning
    [J]. CLINICAL DRUG INVESTIGATION, 2012, 32 (12) : 791 - 798
  • [10] Pharmacokinetics and Safety of Ezetimibe/Simvastatin Combination TabletAn Open-Label, Single-Dose Study in Healthy Chinese Subjects
    Nan-Nan Chu
    Wei-Li Chen
    Hong-Rong Xu
    Xue-Ning Li
    [J]. Clinical Drug Investigation, 2012, 32 : 791 - 798
12345